Medicxi Ventures Management (Jersey) Ltd
Follow13F filer, CIK 1715579, ST. HELIER, Jersey
Medicxi Ventures Management (Jersey) Ltd reported $528,890,559 across 4 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-10-15.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-009687
- Period
- 2024-09-30
- Reported value
- $529M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0000950123-24-009687, largest first. % of portfolio is the value over $528,890,559, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| CNTACENTESSA PHARMACEUTICALS PLC | 19,963,157 | $319M | 60.35% | 0 | Timeline | ||
| PHATPHATHOM PHARMACEUTICALS INC | 7,464,572 | $135M | 25.52% | 0 | Timeline | ||
| NAMSNEWAMSTERDAM PHARMA COMPANY | 2,869,565 | $47.6M | 9.01% | 0 | Timeline | ||
| AURAAURA BIOSCIENCES INC | 3,039,892 | $27.1M | 5.12% | 0 | Timeline |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-24-009687 | base | 2024-10-15 | acceptance time not in the bulk data set |